Abstract:
:Clinical trials often assess efficacy by comparing treatments on the basis of two or more event-time outcomes. In the case of cancer clinical trials, progression-free survival (PFS), which is the minimum of the time from randomization to progression or to death, summarizes the comparison of treatments on the hazards for disease progression and mortality. However, the analysis of PFS does not utilize all the information we have on patients in the trial. First, if both progression and death times are recorded, then information on death time is ignored in the PFS analysis. Second, disease progression is monitored at regular clinic visits, and progression time is recorded as the first visit at which evidence of progression is detected. However, many patients miss or have irregular visits (resulting in interval-censored data) and sometimes die of the cancer before progression was recorded. In this case, the previous progression-free time could provide additional information on the treatment efficacy. The aim of this paper is to propose a method for comparing treatments that could more fully utilize the data on progression and death. We develop a test for treatment effect based on of the joint distribution of progression and survival. The issue of interval censoring is handled using the very simple and intuitive approach of the Conditional Expected Score Test (CEST). We focus on the application of these methods in cancer research.
journal_name
Stat Medjournal_title
Statistics in medicineauthors
Finkelstein DM,Schoenfeld DAdoi
10.1002/sim.6096subject
Has Abstractpub_date
2014-05-30 00:00:00pages
1981-9issue
12eissn
0277-6715issn
1097-0258journal_volume
33pub_type
杂志文章abstract::Austin Bradford Hill was once a friend to The Lancet, but, as occasionally happens, friends fall out. The great legacy of his association with the journal, however, was Principles of Medical Statistics. As each edition was succeeded by another--the first in 1937, the last in 1991--he seemed to shift his view about the...
journal_title:Statistics in medicine
pub_type: 传
doi:10.1002/1097-0258(20001215)19:23<3149::aid-sim617>
更新日期:2000-12-15 00:00:00
abstract::Cancer immunotherapy trials have two special features: a delayed treatment effect and a cure rate. Both features violate the proportional hazard model assumption and ignoring either one of the two features in an immunotherapy trial design will result in substantial loss of statistical power. To properly design immunot...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8440
更新日期:2020-03-15 00:00:00
abstract::We develop parametric maximum likelihood methods to adjust for treatment changes during follow-up in order to assess the causal effect of treatment in clinical trials with time-to-event outcomes. The accelerated failure time model of Robins and Tsiatis relates each observed event time to the underlying event time that...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.1618
更新日期:2004-02-28 00:00:00
abstract::In record linkage studies, unique identifiers are often not available, and therefore, the linkage procedure depends on combinations of partially identifying variables with low discriminating power. As a consequence, wrongly linked covariate and outcome pairs will be created and bias further analysis of the linked data...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.5498
更新日期:2012-12-30 00:00:00
abstract::For many HIV-infected patients, use of antiretroviral therapy (ART) results in a sustained suppression of plasma viral load to undetectable levels. However, due to lack of antigenic stimulation, this may also result in a gradual loss of cell-mediated immune (CMI) responses that help control HIV infection. In concept, ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.2555
更新日期:2007-02-10 00:00:00
abstract::The sample size required for a cluster randomised trial is inflated compared with an individually randomised trial because outcomes of participants from the same cluster are correlated. Sample size calculations for longitudinal cluster randomised trials (including stepped wedge trials) need to take account of at least...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.7028
更新日期:2016-11-20 00:00:00
abstract::The percentile-finding experimental design known variously as 'forced-choice fixed-staircase', 'geometric up-and-down' or 'k-in-a-row' (KR) was introduced by Wetherill four decades ago. To date, KR has been by far the most widely used up-and-down (U&D) design for estimating non-median percentiles; it is implemented mo...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.3590
更新日期:2009-06-15 00:00:00
abstract::A general method is presented that allows the researcher to change statistical design elements such as the residual sample size during the course of an experiment, to include an interim analysis for early stopping when no formal rule for early stopping was foreseen, to increase or reduce the number of planned interim ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.1852
更新日期:2004-08-30 00:00:00
abstract::The cost and efficiency of training clinical centre staff and of duplicate data entry in clinical trials is reviewed. Training is an essential component of quality assurance programmes and it is usually carried out at regular intervals in long-term clinical trials. Initial training of staff and regular retraining is i...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780090118
更新日期:1990-01-01 00:00:00
abstract::Often in randomized clinical trials and observational studies in occupational and environmental health, a non-negative continuously distributed response variable denoting some metabolites of environmental toxicants is measured in treatment and control groups. When observations occur in both unexposed and exposed subje...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.3170
更新日期:2008-06-15 00:00:00
abstract::This paper considers the problem of selecting a set of regressors when the response variable is distributed according to a specified parametric model and observations are censored. Under a Bayesian perspective, the most widely used tools are Bayes factors (BFs), which are undefined when improper priors are used. In or...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6249
更新日期:2014-11-20 00:00:00
abstract::The analysis and recognition of disease clustering in space and its representation on a map is an important problem in epidemiology. An approach using mixture models to identify spatial heterogeneity in disease risk and map construction within an empirical Bayes framework is described. Once heterogeneity is detected, ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/(sici)1097-0258(19960415)15:7/9<919::aid-s
更新日期:1996-04-15 00:00:00
abstract::Motivated by a previously published study of HIV treatment, we simulated data subject to time-varying confounding affected by prior treatment to examine some finite-sample properties of marginal structural Cox proportional hazards models. We compared (a) unadjusted, (b) regression-adjusted, (c) unstabilized, and (d) s...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.5317
更新日期:2012-08-30 00:00:00
abstract::In this paper, we define a modified version τ(b) of Kendall's tau to measure the association in a pair (X,Y) of random variables subject to fixed left censoring due to known lower detection limits. We provide a nonparametric estimator of τ(b) and investigate its asymptotic properties. We then assume an Archimedean cop...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4319
更新日期:2011-11-20 00:00:00
abstract::The 'landmark' and 'Simon and Makuch' non-parametric estimators of the survival function are commonly used to contrast the survival experience of time-dependent treatment groups in applications such as stem cell transplant versus chemotherapy in leukemia. However, the theoretical survival functions corresponding to th...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6765
更新日期:2016-03-30 00:00:00
abstract::It is unclear to what extent the incremental predictive performance of a novel biomarker is impacted by the method used to control for standard predictors. We investigated whether adding a biomarker to a model with a published risk score overestimates its incremental performance as compared to adding it to a multivari...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6165
更新日期:2014-07-10 00:00:00
abstract::In the medical literature, hundreds of prediction models are being developed to predict health outcomes in individuals. For continuous outcomes, typically a linear regression model is developed to predict an individual's outcome value conditional on values of multiple predictors (covariates). To improve model developm...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.7993
更新日期:2019-03-30 00:00:00
abstract::Estimating the causal effect of quitting smoking on time to death or first myocardial infarction requires that one control for the differences in risk factors between individuals who elect to quite at each time t versus those who elect to continue smoking at time t. In this paper we examine the limitations of standard...
journal_title:Statistics in medicine
pub_type: 杂志文章,多中心研究
doi:10.1002/sim.4780121707
更新日期:1993-09-15 00:00:00
abstract::In a medical study we are often interested in graphically displaying the relationship between continuous variables and clinical events indicating disease progression. Often, it is reasonable to make the minimal assumption that the risk of progression is an arbitrary monotone function of the continuous variable. Someti...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.1561
更新日期:2003-10-30 00:00:00
abstract::In this article we develop flexible regression models in two respects to evaluate the influence of the covariate variables on the mixed Poisson and continuous responses and to evaluate how the correlation between Poisson response and continuous response changes over time. A scenario for dealing with regression models ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.2776
更新日期:2007-09-10 00:00:00
abstract::The analysis of repeated measures data can be conducted efficiently using a two-level random coefficients model. A standard assumption is that the within-individual (level 1) residuals are uncorrelated. In some cases, especially where measurements are made close together in time, this may not be reasonable and this ad...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780131605
更新日期:1994-08-30 00:00:00
abstract::Identification of key factors associated with the risk of developing cardiovascular disease and quantification of this risk using multivariable prediction algorithms are among the major advances made in preventive cardiology and cardiovascular epidemiology in the 20th century. The ongoing discovery of new risk markers...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.2929
更新日期:2008-01-30 00:00:00
abstract::We propose a new design for dose finding for cytotoxic agents in two ordered groups of patients. By ordered groups, we mean that prior to the study there is clinical information that would indicate that for a given dose one group would be more susceptible to toxicities than patients in the other group. The designs are...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.7133
更新日期:2017-01-30 00:00:00
abstract::Multilevel and longitudinal studies are frequently subject to missing data. For example, biomarker studies for oral cancer may involve multiple assays for each participant. Assays may fail, resulting in missing data values that can be assumed to be missing completely at random. Catellier and Muller proposed a data ana...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6811
更新日期:2016-07-30 00:00:00
abstract::Estimates of transmission probabilities for sexually transmitted diseases historically come from studies of uninfected individuals exposed to those with a high disease prevalence (for example, prostitutes). However, changes in sexual behaviour, much of which relates to concerns about AIDS, has made identification of p...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780110502
更新日期:1992-03-01 00:00:00
abstract::In many biomedical and epidemiological studies, data are often clustered due to longitudinal follow up or repeated sampling. While in some clustered data the cluster size is pre-determined, in others it may be correlated with the outcome of subunits, resulting in informative cluster size. When the cluster size is info...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4239
更新日期:2011-07-10 00:00:00
abstract::A stochastic approximation EM algorithm (SAEM) is described for exploratory factor analysis of dichotomous or ordinal variables. The factor structure is obtained from sufficient statistics that are updated during iterations with the Robbins-Monro procedure. Two large-scale simulations are reported that compare accurac...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8217
更新日期:2019-09-20 00:00:00
abstract::The change in c-statistic is frequently used to summarize the change in predictive accuracy when a novel risk factor is added to an existing logistic regression model. We explored the relationship between the absolute change in the c-statistic, Brier score, generalized R(2) , and the discrimination slope when a risk f...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.5598
更新日期:2013-02-20 00:00:00
abstract::Motivated by a study about prompt coronary angiography in myocardial infarction, we propose a method to estimate the causal effect of a treatment in two-arm experimental studies with possible noncompliance in both treatment and control arms. We base the method on a causal model for repeated binary outcomes (before and...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.5856
更新日期:2013-11-10 00:00:00
abstract::In observational studies with censored data, exposure-outcome associations are commonly measured with adjusted hazard ratios from multivariable Cox proportional hazards models. The difference in restricted mean survival times (RMSTs) up to a pre-specified time point is an alternative measure that offers a clinically m...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8206
更新日期:2019-09-10 00:00:00